effective strategy to further enhance the anti-tumor effects of T-cell therapy. Chimeric antigen receptor T-cell therapy and T-cell receptor-engineered T-cell therapy are two directions ... models of various targeted…
those who have failed BTKi treatment, indicating a high unmet need for novel therapies. Chimeric Antigen Receptor (CAR) T-cell therapy has been approved for the treatment ... relma-cel, a cellular therapy comprising…
transplantation. Specifically, we discuss the use of regulatory T-cells (Tregs) to suppress autoimmunity, chimeric antigen receptor T-cell (CAR-T) therapy for cancer treatment, and hematopoietic stem cell…
patients. The BRCA analysis was inconclusive due to the specimen being chimeric, or having two distinct genetic profiles. We propose the Vanishing Twin theory as the most probable explanation ... attempt to understand…
antigens to the target cells. We analyzed immune epitopes of ScaAB protein and modeled chimeric influenza proteins carrying various combinations of ScaAB epitopes. Methods: Three-dimensional structure of chimeric…
Chimeric Antigen Receptor T-cell (CAR-T) therapy has emerged as a groundbreaking immunotherapeutic approach for treating hematologic malignancies and is being investigated for solid tumors. This innovative strategy…
Breast Chimeric Antigen Receptor (CAR) T cell therapy is a groundbreaking form of cancer treatment that harnesses the power of the immune system to target and destroy cancer cells
Hematologic malignancies have demonstrated good results with chimeric antigen receptor (CAR) T cell treatment. CAR T cells' antitumor activity, on the other hand, needs to be improved in order
restrict the propagation of human metapneumovirus (hMPV) in host cells by designing a chimeric construct encoding N gene specific shRNA linked through an intracellular cleavable linker to a ribozyme targeted…
against these viral infections dramatically reduces the incidence of associated tumors. CAR-T cells (Chimeric Antigen Receptor, or antigenic receptor chimeric): it consists of extracting the patient's immune cells
therapeutic peptide. As an MMP-activable therapeutic model molecule, pore-forming bufforin IIb chimeric peptide with GO-anchoring peptide at the end was designed. GO loaded with imaging probe derivative ... bufforin…
human carcinomas and plays a key role in the progression and tumorigenesis. MUC1 specific chimeric antigen receptors (CARs) modified T/NK cells has been shown to be an effective approach ... clinically applicable NK-92…
against these viral infections dramatically reduces the incidence of associated tumors. CAR-T cells (Chimeric Antigen Receptor, or antigenic receptor chimeric): it consists of extracting the patient's immune cells
potency. Cellular modification strategies include pulsing DCs with tumor antigens/lysate and expression of chimeric antigen receptors or modified T-cell receptors (TCRs) on T cells and NK cells
such as the ability to genetically engineer T cells with T cell receptors and chimeric antigen receptors (CAR) against shared tumor antigens have sparked new interest and enthusiasm for ATCT
Recombinant immunotoxins are antibody-toxin chimeric molecules that kill cancer cells via binding to a surface antigen, internalization and delivery of the toxin moiety to the cell cytosol. Immunotoxins target ... human…
Adoptive immunotherapy involving genetic modification of T cells with chimeric antigen receptors (CAR’s) is a promising approach for treatment of cancer although has resulted in on target toxicity ... mammary tissue to…
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.